Cynthia Antonio
Family · Orange, CANPI 1962745554
Payments from drug & device makers
Across 378 payments — averaging $17.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$1K
- Mannkind Corporation$707
- Novo Nordisk$646
- Amgen$538
- AstraZeneca$425
- Embecta Corp.$242
- plus $3K from 25 others
What the payments were for
- Food & beverage$6,746100%
- Education$230%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 93 | $1,441 |
| Mannkind Corporation | 41 | $707 |
| Novo Nordisk | 44 | $646 |
| Amgen(2 entities) | 32 | $538 |
| AstraZeneca(2 entities) | 20 | $425 |
| Embecta Corp. | 9 | $242 |
| AbbVie | 14 | $242 |
| Abbott | 11 | $231 |
| Bayer | 8 | $215 |
| Boehringer Ingelheim | 8 | $213 |
| Bigfoot Biomedical Inc | 18 | $210 |
| Novartis | 10 | $203 |
| Cequr Corporation | 2 | $172 |
| Radius Health, Inc. | 7 | $158 |
| Dexcom, Inc. | 7 | $114 |
| Sanofi-aventis U.S. LLC | 7 | $104 |
| Pfizer | 5 | $102 |
| Merck | 7 | $99 |
| Zealand Pharma US, Inc. | 6 | $94 |
| Tandem Diabetes Care, Inc. | 4 | $92 |
| Kyowa Kirin, Inc. | 3 | $76 |
| Corcept Therapeutics | 3 | $73 |
| Xeris Pharmaceuticals, Inc. | 4 | $70 |
| Insulet Corporation | 3 | $68 |
| IBSA Pharma Inc. | 3 | $56 |
| BD | 1 | $40 |
| Medtronic | 2 | $36 |
| Amryt Pharma Holdings Ltd | 2 | $35 |
| Currax Pharmaceuticals LLC | 2 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $22 |
| Halozyme Inc | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CeQur Simplicity$146
- AFREZZA$125
- TEPEZZA$112
How this compares
$6,770 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 69 | $86,127 |
| TrulicityDulaglutide | 26 | $46,904 |
| FarxigaDapagliflozin Propanediol | 42 | $44,992 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 37 | $30,675 |
| JardianceEmpagliflozin | 18 | $29,627 |
| MounjaroTirzepatide | 17 | $25,014 |
| JanuviaSitagliptin Phosphate | 17 | $16,394 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $7,640 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $6,104 |
| Humalog Kwikpen U-100Insulin Lispro | 25 | $6,035 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 32 | $4,015 |
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 13 | $1,845 |
| Levothyroxine Sodium | 65 | $1,792 |
| SynthroidLevothyroxine Sodium | 18 | $1,718 |
| Pioglitazone Hcl | 57 | $972 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $646 | $86,12769 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $1,441 | $71,91843 claims |
| AstraZenecaFarxiga | $425 | $44,99242 claims |
| Boehringer IngelheimJardiance | $213 | $29,62718 claims |
| MerckJanuvia | $99 | $16,39417 claims |
| AbbVieSynthroid | $242 | $1,71818 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 10,634 family providers in California.
Other family in Orange
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.